179 related articles for article (PubMed ID: 23935884)
1. Overexpression of high mobility group A1 protein in human uveal melanomas: implication for prognosis.
Qu Y; Wang Y; Ma J; Zhang Y; Meng N; Li H; Wang Y; Wei W
PLoS One; 2013; 8(7):e68724. PubMed ID: 23935884
[TBL] [Abstract][Full Text] [Related]
2. HMGA1 exacerbates tumor progression by activating miR-222 through PI3K/Akt/MMP-9 signaling pathway in uveal melanoma.
Cheng Y; Cheng T; Zhao Y; Qu Y
Cell Signal; 2019 Nov; 63():109386. PubMed ID: 31394192
[TBL] [Abstract][Full Text] [Related]
3. Prognostic relevance of ATM protein in uveal melanoma and its association with clinicopathological factors.
Jha J; Singh MK; Singh L; Pushker N; Bajaj MS; Sen S; Kashyap S
Int J Clin Oncol; 2019 Dec; 24(12):1526-1535. PubMed ID: 31377937
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of BCL2 19 kD Protein-Interacting Protein 3 (BNIP3) is Predictive of Unfavorable Prognosis in Uveal Melanoma.
Jiang Z; Yu F; Li M
Med Sci Monit; 2018 Jul; 24():4711-4717. PubMed ID: 29982263
[TBL] [Abstract][Full Text] [Related]
5. High mobility group A1 and cancer: potential biomarker and therapeutic target.
Shah SN; Resar LM
Histol Histopathol; 2012 May; 27(5):567-79. PubMed ID: 22419021
[TBL] [Abstract][Full Text] [Related]
6. Nestin expression in primary and metastatic uveal melanoma - possible biomarker for high-risk uveal melanoma.
Djirackor L; Shakir D; Kalirai H; Petrovski G; Coupland SE
Acta Ophthalmol; 2018 Aug; 96(5):503-509. PubMed ID: 29338117
[TBL] [Abstract][Full Text] [Related]
7. Butyrophilin-Like 9 (BTNL9) Suppresses Invasion and Correlates with Favorable Prognosis of Uveal Melanoma.
Jiang Z; Liu F
Med Sci Monit; 2019 Apr; 25():3190-3198. PubMed ID: 31039142
[TBL] [Abstract][Full Text] [Related]
8. ADAM 10 expression in primary uveal melanoma as prognostic factor for risk of metastasis.
Caltabiano R; Puzzo L; Barresi V; Ieni A; Loreto C; Musumeci G; Castrogiovanni P; Ragusa M; Foti P; Russo A; Longo A; Reibaldi M
Pathol Res Pract; 2016 Nov; 212(11):980-987. PubMed ID: 27546281
[TBL] [Abstract][Full Text] [Related]
9. Exploring the role of BAFF as biomarker in the detection of uveal melanoma metastases.
Lin Z; Süsskind D
J Cancer Res Clin Oncol; 2021 May; 147(5):1389-1405. PubMed ID: 33665679
[TBL] [Abstract][Full Text] [Related]
10. Translating Proteomic Into Functional Data: An High Mobility Group A1 (HMGA1) Proteomic Signature Has Prognostic Value in Breast Cancer.
Maurizio E; Wiśniewski JR; Ciani Y; Amato A; Arnoldo L; Penzo C; Pegoraro S; Giancotti V; Zambelli A; Piazza S; Manfioletti G; Sgarra R
Mol Cell Proteomics; 2016 Jan; 15(1):109-23. PubMed ID: 26527623
[TBL] [Abstract][Full Text] [Related]
11. Elevated expression of HMGA1 correlates with the malignant status and prognosis of non-small cell lung cancer.
Zhang Z; Wang Q; Chen F; Liu J
Tumour Biol; 2015 Feb; 36(2):1213-9. PubMed ID: 25344216
[TBL] [Abstract][Full Text] [Related]
12. Expression of the SST receptor 2 in uveal melanoma is not a prognostic marker.
Kouch-el Filali M; Kilic E; Melis M; de Klein A; de Jong M; Luyten GP
Graefes Arch Clin Exp Ophthalmol; 2008 Nov; 246(11):1585-92. PubMed ID: 18682975
[TBL] [Abstract][Full Text] [Related]
13. HMGA1 Overexpression is Associated With the Malignant Status and Progression of Breast Cancer.
Qi C; Cao J; Li M; Liang C; He Y; Li Y; Li J; Zheng X; Wang L; Wei B
Anat Rec (Hoboken); 2018 Jun; 301(6):1061-1067. PubMed ID: 29316384
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of HERC2 protein and pink-eyed dilution protein in uveal melanoma.
Kashyap S; Singh MK; Jha J; Singh L; Pushker N; Sen S; Venkatesh P; Meel R; Lomi N
Hum Cell; 2020 Oct; 33(4):1264-1272. PubMed ID: 32686068
[TBL] [Abstract][Full Text] [Related]
15. High mobility group A1 (HMGA1) protein and gene expression correlate with ER-negativity and poor outcomes in breast cancer.
Gorbounov M; Carleton NM; Asch-Kendrick RJ; Xian L; Rooper L; Chia L; Cimino-Mathews A; Cope L; Meeker A; Stearns V; Veltri RW; Bae YK; Resar LMS
Breast Cancer Res Treat; 2020 Jan; 179(1):25-35. PubMed ID: 31531802
[TBL] [Abstract][Full Text] [Related]
16. DNA damage response proteins and its role in tumor progression of uveal melanoma with patient outcome.
Kashyap S; Jha J; Singh MK; Singh L; Sen S; Kaur J; Bajaj MS; Pushker N
Clin Transl Oncol; 2020 Sep; 22(9):1472-1480. PubMed ID: 32124242
[TBL] [Abstract][Full Text] [Related]
17. Expression of Fas and Fas ligand in uveal melanoma: biological implication and prognostic value.
Anastassiou G; Coupland SE; Stang A; Boeloeni R; Schilling H; Bornfeld N
J Pathol; 2001 Aug; 194(4):466-72. PubMed ID: 11523055
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of thrombospondin 2 inhibits metastasis through modulation of PI3K signaling pathway in uveal melanoma cell line M23.
Liu QH; Ma LS
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6230-6238. PubMed ID: 30338785
[TBL] [Abstract][Full Text] [Related]
19. Differential expression and prognostic value of HMGA1 in pancreatic head and periampullary cancer.
van der Zee JA; ten Hagen TL; Hop WC; van Dekken H; Dicheva BM; Seynhaeve AL; Koning GA; Eggermont AM; van Eijck CH
Eur J Cancer; 2010 Dec; 46(18):3393-9. PubMed ID: 20724141
[TBL] [Abstract][Full Text] [Related]
20. Fra-1 Regulates the Expression of HMGA1, Which is Associated with a Poor Prognosis in Human Esophageal Squamous Cell Carcinoma.
Toyozumi T; Hoshino I; Takahashi M; Usui A; Akutsu Y; Hanari N; Murakami K; Kano M; Akanuma N; Suitoh H; Matsumoto Y; Sekino N; Komatsu A; Matsubara H
Ann Surg Oncol; 2017 Oct; 24(11):3446-3455. PubMed ID: 27882471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
